172 related articles for article (PubMed ID: 26851308)
21. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
Foss B; Mentzoni L; Bruserud O
J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
[TBL] [Abstract][Full Text] [Related]
22. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
[TBL] [Abstract][Full Text] [Related]
23. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
24. [Expression of vascular endothelial growth factor and its receptors KDR and Flt1 in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Yang C; Yang RC; Cai YL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):249-52. PubMed ID: 12859876
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of fibroblastic cells in long-term marrow cultures from patients with acute myelogenous leukemia.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Leukemia; 1993 Oct; 7(10):1564-9. PubMed ID: 8412319
[TBL] [Abstract][Full Text] [Related]
26. A possible role for spontaneous interleukin-8 production by acute myeloid leukemic cells in angiogenesis related processes: work in progress.
de Bont ES; Vellenga E; Molema G; van Wering E; de Leij LF; Kamps WA
Med Pediatr Oncol; 2001 Dec; 37(6):511-7. PubMed ID: 11745889
[TBL] [Abstract][Full Text] [Related]
27. Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.
Hiramatsu A; Miwa H; Shikami M; Ikai T; Tajima E; Yamamoto H; Imai N; Hattori A; Kyo T; Watarai M; Miura K; Satoh A; Itoh M; Imamura A; Mihara H; Katoh Y; Nitta M
Leuk Lymphoma; 2006 Jan; 47(1):89-95. PubMed ID: 16465716
[TBL] [Abstract][Full Text] [Related]
28. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
29. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics.
Virtaneva K; Wright FA; Tanner SM; Yuan B; Lemon WJ; Caligiuri MA; Bloomfield CD; de La Chapelle A; Krahe R
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1124-9. PubMed ID: 11158605
[TBL] [Abstract][Full Text] [Related]
30. Identification of differentially expressed genes in human embryonic stem cell-derived endothelial cells using suppression subtractive hybridization.
Ahn JS; Moon SH; Kim J; Chung HM; Kim JK
Stem Cells Dev; 2010 Aug; 19(8):1249-56. PubMed ID: 19817571
[TBL] [Abstract][Full Text] [Related]
31. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
Riccioni R; Diverio D; Mariani G; Buffolino S; Riti V; Saulle E; Petrucci E; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
Stem Cells; 2007 Aug; 25(8):1862-71. PubMed ID: 17446561
[TBL] [Abstract][Full Text] [Related]
32. Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.
Tentori L; Vergati M; Muzi A; Levati L; Ruffini F; Forini O; Vernole P; Lacal PM; Graziani G
Int J Oncol; 2005 Aug; 27(2):525-35. PubMed ID: 16010436
[TBL] [Abstract][Full Text] [Related]
33. Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells.
Hatfield KJ; Reikvam H; Bruserud Ø
Expert Opin Ther Targets; 2014 Nov; 18(11):1237-51. PubMed ID: 25200484
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
[TBL] [Abstract][Full Text] [Related]
35. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
[TBL] [Abstract][Full Text] [Related]
36. Functional integration of acute myeloid leukemia into the vascular niche.
Cogle CR; Goldman DC; Madlambayan GJ; Leon RP; Masri AA; Clark HA; Asbaghi SA; Tyner JW; Dunlap J; Fan G; Kovacsovics T; Liu Q; Meacham A; Hamlin KL; Hromas RA; Scott EW; Fleming WH
Leukemia; 2014 Oct; 28(10):1978-1987. PubMed ID: 24637335
[TBL] [Abstract][Full Text] [Related]
37. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.
Hatfield K; Ryningen A; Corbascio M; Bruserud O
Int J Cancer; 2006 Nov; 119(10):2313-21. PubMed ID: 16921487
[TBL] [Abstract][Full Text] [Related]
38. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia.
Tian C; Yu Y; Jia Y; Zhu L; Zhang Y
Ann Hematol; 2015 Sep; 94(9):1477-83. PubMed ID: 26092281
[TBL] [Abstract][Full Text] [Related]
39. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression.
Loomans CJ; Wan H; de Crom R; van Haperen R; de Boer HC; Leenen PJ; Drexhage HA; Rabelink TJ; van Zonneveld AJ; Staal FJ
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1760-7. PubMed ID: 16728651
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
